[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Seastar Medical Hldg Corp (ICU)

Seastar Medical Hldg Corp (ICU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 15,988
  • Shares Outstanding, K 3,997
  • Annual Sales, $ 1,230 K
  • Annual Income, $ -12,150 K
  • EBIT $ -12 M
  • EBITDA $ -12 M
  • 60-Month Beta -1.04
  • Price/Sales 12.79
  • Price/Cash Flow N/A
  • Price/Book 2.29

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.71
  • Number of Estimates 1
  • High Estimate $-0.71
  • Low Estimate $-0.71
  • Prior Year $-1.80
  • Growth Rate Est. (year over year) +60.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.72 +7.65%
on 04/28/26
5.10 -21.56%
on 05/07/26
-0.20 (-4.76%)
since 04/17/26
3-Month
2.07 +93.24%
on 03/24/26
5.10 -21.56%
on 05/07/26
+1.55 (+63.27%)
since 02/18/26
52-Week
2.07 +93.24%
on 03/24/26
13.40 -70.15%
on 05/22/25
-8.40 (-67.74%)
since 05/16/25

Most Recent Stories

More News
SeaStar Medical Reports First Quarter Financial Results and Provides Business Updates

Added 7 top-rated children’s hospitals to QUELIMMUNE ® pediatric acute kidney injury (AKI) customer base, increasing first quarter revenue 69% versus first quarter 2025 revenue Advanced enrollment...

ICU : 4.00 (+1.27%)
SeaStar Medical to Report First Quarter Financial Results on May 13, 2026

DENVER, May 06, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing...

ICU : 4.00 (+1.27%)
SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026

Results from pediatric patients in the SAVE Registry shows no device-related adverse events or immunosuppression and continued strong survival data  In vitro analysis of the SeaStar Medical SCD indicates...

ICU : 4.00 (+1.27%)
SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Added top-rated children’s hospitals to QUELIMMUNE™ pediatric Acute Kidney Injury (AKI) customer base Completed enrollment in FDA-mandated QUELIMMUNE SAVE Post-Marketing Registry Exceeded...

ICU : 4.00 (+1.27%)
SeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026

DENVER, March 18, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing...

ICU : 4.00 (+1.27%)
SeaStar Medical Announces Completion of FDA Enrollment Requirement for SAVE Surveillance Registry Evaluating QUELIMMUNE Safety for Pediatric AKI

DENVER, March 05, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company, announced today that it has completed the required enrollment in the...

ICU : 4.00 (+1.27%)
SeaStar Medical Announces Publication in Pediatric Nephrology of Positive Real-World Experience for QUELIMMUNEâ„¢ (SCD-PED) Therapy in Pediatric Acute Kidney Injury (AKI)

Strong survival data extending to 90 days Real-world experience shows results consistent with clinical trial data Favorable safety profile – no device-related adverse events DENVER, Feb....

ICU : 4.00 (+1.27%)
SeaStar Medical to Present at Upcoming Noble Capital Markets Emerging Growth Virtual Equity Conference

DENVER, Jan. 29, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing...

ICU : 4.00 (+1.27%)
SeaStar Medical Announces 2026 Milestones

Drive adoption of QUELIMMUNE for ultra-rare pediatric AKI, expanding revenue and doubling the customer base Advance SeaStar Medical’s first-in-class SCD therapy for the adult AKI indication –...

ICU : 4.00 (+1.27%)
SeaStar Medical to Present at Upcoming Biotech Showcase 2026 Investor Conference

DENVER, Jan. 06, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing...

ICU : 4.00 (+1.27%)

Business Summary

SeaStar Medical Holding Corporation is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. SeaStar Medical Holding Corporation, formerly known as LMF Acquisition Opportunities Inc., is based in Denver, Colorado.

See More

Key Turning Points

3rd Resistance Point 4.27
2nd Resistance Point 4.17
1st Resistance Point 4.09
Last Price 4.00
1st Support Level 3.90
2nd Support Level 3.80
3rd Support Level 3.72

See More

52-Week High 13.40
Fibonacci 61.8% 9.07
Fibonacci 50% 7.73
Fibonacci 38.2% 6.40
Last Price 4.00
52-Week Low 2.07

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.